iMeds.se

Ovixan

Information för alternativet: Ovixan 1 Mg/G Kutan Lösning, visa andra alternativ
Document: Ovixan cutaneous solution ENG PL change

PACKAGE LEAFLET


PACKAGE LEAFLET: INFORMATION FOR THE USER


Ovixan 1 mg/g cutaneous solution


Mometasone furoate



In this leaflet:

1. What Ovixan is and what it is used for

2. Before you use Ovixan

3. How to use Ovixan

4. Possible side effects

How to store Ovixan

6. Further information



What Ovixan is and what is is used for


Ovixan contains the active substance mometasone furoate and it is a corticosteroid for cutaneous use. Corticosteroids for cutaneous use are divided into four classes depending on strength and effect: mild effect, medium effect, strong effect and very strong effect. Mometasone furoate belongs to the class “corticosteroid with strong effect”.


Adults and children above 6 years:

Ovixan has an anti-inflammatory effect and reduces itchiness. Ovixan is used to decrease symptoms in connection with inflammatory skin conditions that can be treated with a corticosteroid, e. g. psoriasis (excluding widespread plaque psoriasis) and some types of dermatitis. It does not cure your skin disease, but it relieves your symptoms.


What you need to know before you use Ovixan


Do not use Ovixan


Warnings and precautions


Other medicines and Ovixan

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, and other cures or dietary supplements such as vitamins. Consult your doctor before using other medicines.


Pregnancy, breast-feeding and fertility

It you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.


Treatment with Ovixan during pregnancy or breast-feeding may only be started after instructions from your doctor.


If your doctor prescribes use of the solution during pregnancy or breast-feeding you must avoid using large quantities and you must only use the solution during a short period of time. Ovixan should not be applied on the breast or on adjacent skin during breast-feeding.



Ovixan contains propylene glycol

Ovixan contains propylene glycol that may cause skin irritation.


How to use Ovixan


Ovixan is intended for cutaneous (external) use. Ovixan may only be used on the skin.



Dosage:

Carefully apply a thin layer of solution on the affected skin once daily. You should only use a small amount of the solution.The bottle has a dropper that makes it easier to apply the solution. Never use a larger amount, and do not use it more often than advised by your doctor or pharmacist.


Adults, including older people:

Do not use the solution on large areas (more that 20 % of the skin surface) or for a long period of time.


Use in children (6 years of age and over):


Children below 6 years:

Ovixan is not recommended for children below 6 years.


If you use more Ovixan than you should

If you swallow the solution by mistake this should not lead to any adverse effects.


If you have not followed your doctors instructions and you have used the solution too often and/or during a long period you should ask your doctor or pharmacist for advice.


If you forget to use Ovixan

If you forget to apply the solution at the time when you should, do it as soon as you remember and then continue as before. Do not use the double amount and do not apply the solution twice in a day to compensate for a forgotten treatment.


If you stop using Ovixan

Do not stop treatment suddenly if you have used the solution for a long time since this can be harmful. The treatment should be gradually decreased according to your doctors instructions.


If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


4. Possible side effects


Like all medicines, this medicine can cause side effects, although not everybody gets them.


Side effects in children and adults that have been reported during use of corticosteroids for cutaneous use include:


Very rare (may affect up to 1 in 10,000 people):

-Inflammation of the hair follicles

-Itching

-Increased superficial blood vessels or spider vains

-Burning sensation


Not known (frequency cannot be estimated from the available data)

-Pain or other reactions at the application site

-Secondary infections (an infection that appears during or after treatment of another infection or disease)

-Ulcers in the face

-Paresthesia (abnormal or numbing sensation on the skin)

-Changes in skin colour

-Skin maceration (softening and bleaching of the skin)

-Miliaria (heat rashes, very itchy rashes)

-Inflammation (including acne like reactions)

-Skin thinning

-Irregular spots or lines on the skin

-Abnormal growth of hair

-Increased sensitivity

-Dryness

Increased use, treatment of larger skin surfaces, longterm use and treatment with occlusion may increase the risk for side effects.


Corticosteroids may affect the normal hormone production of the body. This is more likely during use of high doses during a longer time period.


Additional side effects in children

In particular children that are treated with corticosteroid solutions, creams and ointments may absorb the product through the skin, which can lead to a disease called Cushing’s syndrome. This syndrome has many symptoms, among these development of a rounder face and weakness.

Growth in children may be inhibited during longterm use. Your doctor will prevent this risk by prescribing the lowest possible corticosteroid dose for a controlled treatment of your symptoms.


Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.

You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.


5. How to store Ovixan


Keep this medicine out of the sight and reach of children.


Do not use Ovixan after the expiry date which is stated on the bottle and carton after Exp. The expiry date refers to the last day of that month.


Do not store above 30°C.


Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.


6. Contents of the pack and other information


What Ovixan contains



Please see section 2Ovixan contains propylene glycol”.


What Ovixan looks like and contents of the pack


Ovixan 1 mg/g cutaneous solution is a colourless to slightly yellow low-viscous solution filled in white polyethylene bottles with a dropper and a white screwcap of polyethylene.


Pack-sizes: 30 ml, 100 ml and 2x100 ml

Not all pack-sizes may be marketed.


Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder

Galenica AB

P A Hanssons väg 41

SE-203 12 Malmö

Sweden


Manufacturer

Laboratorio Reig Jofré S.A.

Gran Capitán 10

Sant Joan Despí

08970 Barcelona

Spain


This medicinal product is authorised in the Member States of the EEA under the following names:


Country

Trade names

Czech Republic

OVIXAN 1 MG/G kožní roztok

Denmark

Ovison 1mg/g Kutanopløsning

Finland

Ovixan 1 mg/g Liuos iholle

Iceland

Ovixan 1 mg/g Húðlausn

Italy

OVISON 1 MG/G SOLUZIONE CUTANEA

Norway

Ovixan 0.1% Liniment oppløsning

Poland

Ovixan 1 mg/g roztwór na skórę

Slovenia

Ovixan 1 mg/g dermalna raztopina

Sweden

Ovixan 1 mg/g Kutan lösning




This leaflet was last revised in 2015-04-07


5